TBXpert: Innovative diagnostics for multidrug-resistant tuberculosis (MDR-TB)
View More
Unitaid-funded projects develop innovative medicines, diagnostic tools and public health techniques and link them quickly, and at affordable prices, to those most in need.
Our grant projects apply the best that science has to offer to the fight against HIV and co-infections, tuberculosis and malaria in lower-resource countries.
Grant focus
Scale up access to and reduce the cost of the Xpert MTB/RIF test
Grantees
Global TB Programme
Status
Complete
Amount
US $25,899,970
Disease
Tuberculosis
View More
Grant focus
Negotiate voluntary licenses to enable the manufacture of low-cost, high-quality HIV, hepatitis C and tuberculosis medicines for lower-resource countries
Grantees
Medicines Patent Pool
Status
Current
Amount
US $60,366,687
Disease
Cross-cutting
View More
Grant focus
Create a market for the most effective malaria treatments through a private-sector subsidy
Grantees
Global Fund
Status
Complete
Amount
US $210,971,000
Disease
Malaria
View More
Grant focus
Linking HIV positive mothers with paediatric HIV care and treatment, and providing nutritional care for pregnant and lactating women
Grantees
UNICEF
Status
Complete
Amount
US $98,793,000
Disease
HIV and Co-Infection
View More
Grant focus
Improve supply chains so that antiretroviral medication reaches treatment centres
Grantees
Ensemble pour une Solidarité Thérapeutique en Réseau (ESTHER)
Status
Complete
Amount
US $14,681,000
Disease
HIV and Co-Infection
View More
Grant focus
Secure funding to prevent stock-outs of nets at crucial distribution times
Grantees
UNICEF
Status
Complete
Amount
US$ 109,246,140
Disease
Malaria
View More
Grant focus
Introduce state-of-the-art, quality-assured diagnostic technologies and laboratory services to countries affected by tuberculosis
Grantees
Global Laboratory Initiative (GLI), World Health Organization
Status
Complete
Amount
US $89,612,000
Disease
Tuberculosis
View More
Grant focus
Establish a stockpile of quality-assured drugs for MDR-TB and stimulate their continued production to avoid stock-outs
Grantees
Global Drug Facility (GDF)
Status
Complete
Amount
US $28,988,000
Disease
Tuberculosis
View More